These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30394904)

  • 21. Event-related potential (ERP) markers of 22q11.2 deletion syndrome and associated psychosis.
    Francisco AA; Foxe JJ; Molholm S
    J Neurodev Disord; 2023 Jun; 15(1):19. PubMed ID: 37328766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychosis in children with velocardiofacial syndrome (22q11.2 deletion syndrome).
    Jolin EM; Weller RA; Weller EB
    Curr Psychiatry Rep; 2009 Apr; 11(2):99-105. PubMed ID: 19302762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Education and employment trajectories from childhood to adulthood in individuals with 22q11.2 deletion syndrome.
    Mosheva M; Pouillard V; Fishman Y; Dubourg L; Sofrin-Frumer D; Serur Y; Weizman A; Eliez S; Gothelf D; Schneider M
    Eur Child Adolesc Psychiatry; 2019 Jan; 28(1):31-42. PubMed ID: 29934817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Psychosis and movement disorders in an adolescent with 22q11.2 deletion syndrome].
    Zinkstok JR; Velders F; Rieken R; Houben M; Fiksinski A; van Amelsvoort TAMJ; Boot E
    Tijdschr Psychiatr; 2020; 62(3):229-233. PubMed ID: 32207133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glutamatergic function in a genetic high-risk group for psychosis: A proton magnetic resonance spectroscopy study in individuals with 22q11.2 deletion.
    Rogdaki M; Hathway P; Gudbrandsen M; McCutcheon RA; Jauhar S; Daly E; Howes O
    Eur Neuropsychopharmacol; 2019 Dec; 29(12):1333-1342. PubMed ID: 31648854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Candidate genes and the behavioral phenotype in 22q11.2 deletion syndrome.
    Prasad SE; Howley S; Murphy KC
    Dev Disabil Res Rev; 2008; 14(1):26-34. PubMed ID: 18636634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The dimensional structure of psychopathology in 22q11.2 Deletion Syndrome.
    Niarchou M; Moore TM; Tang SX; Calkins ME; McDonald-McGuinn DM; Zackai EH; Emanuel BS; Gur RC; Gur RE
    J Psychiatr Res; 2017 Sep; 92():124-131. PubMed ID: 28433949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Spectrum of neuropsychiatric features associated with velocardiofacial syndrome (Deletion 22q11.2)].
    Sieberer M; Runte I; Wilkening A; Pabst B; Ziegenbein M; Haltenhof H
    Fortschr Neurol Psychiatr; 2006 May; 74(5):263-74. PubMed ID: 16758538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and incidence of psychotic disorders in 22q11.2 deletion syndrome: a meta-analysis.
    Provenzani U; Damiani S; Bersano I; Singh S; Moschillo A; Accinni T; Brondino N; Oliver D; Fusar-Poli P
    Int Rev Psychiatry; 2022; 34(7-8):676-688. PubMed ID: 36786112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attenuated positive symptoms of psychosis in adolescents with chromosome 22q11.2 deletion syndrome.
    Stoddard J; Niendam T; Hendren R; Carter C; Simon TJ
    Schizophr Res; 2010 May; 118(1-3):118-21. PubMed ID: 20056393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Striatal dopaminergic alterations in individuals with copy number variants at the 22q11.2 genetic locus and their implications for psychosis risk: a [18F]-DOPA PET study.
    Rogdaki M; Devroye C; Ciampoli M; Veronese M; Ashok AH; McCutcheon RA; Jauhar S; Bonoldi I; Gudbrandsen M; Daly E; van Amelsvoort T; Van Den Bree M; Owen MJ; Turkheimer F; Papaleo F; Howes OD
    Mol Psychiatry; 2023 May; 28(5):1995-2006. PubMed ID: 33981004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychosis spectrum symptoms among individuals with schizophrenia-associated copy number variants and evidence of cerebellar correlates of symptom severity.
    Sefik E; Guest RM; Aberizk K; Espana R; Goines K; Novacek DM; Murphy MM; Goldman-Yassen AE; Cubells JF; Ousley O; Li L; Shultz S; Walker EF; Mulle JG
    Psychiatry Res; 2024 May; 335():115867. PubMed ID: 38537595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal perspectives on the psychosis spectrum in 22q11.2 deletion syndrome.
    Tang SX; Gur RE
    Am J Med Genet A; 2018 Oct; 176(10):2192-2202. PubMed ID: 29048724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Further evidence for high rates of schizophrenia in 22q11.2 deletion syndrome.
    Monks S; Niarchou M; Davies AR; Walters JT; Williams N; Owen MJ; van den Bree MB; Murphy KC
    Schizophr Res; 2014 Mar; 153(1-3):231-6. PubMed ID: 24534796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low prevalence of substance use in people with 22q11.2 deletion syndrome.
    Vingerhoets C; van Oudenaren MJF; Bloemen OJN; Boot E; van Duin EDA; Evers LJM; Fiksinski AM; Breetvelt EJ; Palmer LD; Vergaelen E; Vogels A; Meijer C; Booij J; ; de Haan L; Swillen A; Vorstman JAS; Bassett AS; van Amelsvoort TAMJ
    Br J Psychiatry; 2019 Nov; 215(5):661-667. PubMed ID: 30604657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. No evidence for the presence of genetic variants predisposing to psychotic disorders on the non-deleted 22q11.2 allele of VCFS patients.
    Guipponi M; Santoni F; Schneider M; Gehrig C; Bustillo XB; Kates WR; Morrow B; Armando M; Vicari S; Sloan-Béna F; Gagnebin M; Shashi V; Hooper SR; Eliez S; Antonarakis SE
    Transl Psychiatry; 2017 Feb; 7(2):e1039. PubMed ID: 28221368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prodromal symptoms in adolescents with 22q11.2 deletion syndrome and schizotypal personality disorder.
    Shapiro DI; Cubells JF; Ousley OY; Rockers K; Walker EF
    Schizophr Res; 2011 Jun; 129(1):20-8. PubMed ID: 21507614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergent, remitted and persistent psychosis-spectrum symptoms in 22q11.2 deletion syndrome.
    Tang SX; Moore TM; Calkins ME; Yi JJ; McDonald-McGinn DM; Zackai EH; Emanuel BS; Gur RC; Gur RE
    Transl Psychiatry; 2017 Jul; 7(7):e1180. PubMed ID: 28742080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive behavioral therapy in 22q11.2 microdeletion with psychotic symptoms: What do we learn from schizophrenia?
    Demily C; Franck N
    Eur J Med Genet; 2016 Nov; 59(11):596-603. PubMed ID: 27639442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predominant negative symptoms in 22q11.2 deletion syndrome and their associations with cognitive functioning and functional outcome.
    Schneider M; Van der Linden M; Menghetti S; Glaser B; Debbané M; Eliez S
    J Psychiatr Res; 2014 Jan; 48(1):86-93. PubMed ID: 24189154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.